no statement of use filed
on 18 Apr 2022
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
88829946 filed on 11th Mar 2020
Registration Number
N/A
Correspondent Address
Paul C. Llewellyn
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of an abstract representation of the DNA double helix structure in white and gold. The color black shown in the mark is background and is not part of the mark. pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations basedRead More
chemical compounds and additives for use in pharmaceutical research; chemical compounds and additives for use in the manufacture of pharmaceuticals; diagnostic reagents for research use
pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
No 88829946
No Service/Collective Mark
No 1053686-0002
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
The mark consists of an abstract representation of the DNA double helix structure in white and gold. The color black shown in the mark is background and is not part of the mark.
| Status Date | Action Taken |
|---|---|
| 18th Apr 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 18th Apr 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 14th Sep 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Sep 2021 | SOU EXTENSION 2 GRANTED |
| 12th Sep 2021 | SOU EXTENSION 2 FILED |
| 12th Sep 2021 | TEAS EXTENSION RECEIVED |
| 10th Mar 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Mar 2021 | SOU EXTENSION 1 GRANTED |
| 08th Mar 2021 | SOU EXTENSION 1 FILED |
| 08th Mar 2021 | TEAS EXTENSION RECEIVED |
